Pneumococcal Vaccine Global Market Opportunities And Strategies To 2034

Pneumococcal Vaccine Market 2025 – By Product Type (Pneumococcal Conjugate Vaccine (PCVs), Pneumococcal Polysaccharide Vaccine (PPV)), By Route Of Administration (Intramuscular, Subcutaneous), By Distribution Channel (Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels), By End User (Pediatrics, Adults), And By Region, Opportunities And Strategies – Global Forecast To 2035

Pneumococcal Vaccine Global Market Opportunities And Strategies To 2034

Report Price : $4490.00 $3367.00 | Pages : 338 | Published : September 2025 | Delivery Time: Immediately Info icon | Format : pdf icon

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Regional Data
Pneumococcal Vaccine Global Market Opportunities And Strategies To 2034
Description Table Of Contents Tables & Figures

Market Insights

Related Reports

Pneumococcal Vaccine Market Definition

Pneumococcal vaccines (PCV) are immunizations designed to protect against infections caused by Streptococcus pneumoniae, a bacterium responsible for illnesses such as pneumonia, meningitis, sinusitis, and bloodstream infections. The primary purpose of pneumococcal vaccine is to prevent serious and potentially life-threatening pneumococcal diseases, especially in high-risk groups like infants, older adults, and people with chronic illnesses.

The pneumococcal vaccine market consists of sales by entities (organizations, sole traders and partnerships) of pneumococcal vaccine that are deployed at scheduled intervals, with infant PCV doses at 2, 4, 6 and 12 months, with adult booster doses as recommended by bodies such as the Centers for Disease Control and Prevention (CDC), the US based national public health agency.

Pneumococcal Vaccine Global Market Opportunities And Strategies To 2034 Market Size and growth rate 2025 to 2029: Graph

Pneumococcal Vaccine Market Size

The global pneumococcal vaccine market reached a value of nearly $7,927.45 million in 2024, having grown at a compound annual growth rate (CAGR) of 4.17% since 2019. The market is expected to grow from $7,927.45 million in 2024 to $10,041.97 million in 2029 at a rate of 4.84%. The market is then expected to grow at a CAGR of 4.33% from 2029 and reach $12,411.73 million in 2034.  

Growth in the historic period resulted from the increasing prevalence of pneumococcal contamination, rising healthcare spending, growing awareness of preventive healthcare and increased government immunization programs. Factors that negatively affected growth in the historic period was stringent regulatory requirements and vaccine hesitancy and misinformation.

Going forward, the growing aging population, rising prevalence of chronic respiratory diseases, rising need for pediatric vaccination and growing public health campaigns will drive the growth. Factor that could hinder the growth of the pneumococcal vaccine market in the future include cold chain and storage challenge high cost of vaccines and impact of trade war and tariff.  

Pneumococcal Vaccine Market Drivers

The key drivers of the pneumococcal vaccine market include:

Growing Aging Population

During the forecast period, the growing aging population is expected to propel the growth of the pneumococcal vaccine market. The aging global population is creating a larger at-risk group for pneumococcal infections such as pneumonia and meningitis, due to age-related immune decline, leading to a sustained rise in vaccine demand. In response, healthcare systems and governments are prioritizing preventive measures to lower elderly morbidity and long-term care costs. Pneumococcal vaccination is central to these strategies, strengthening both public immunization campaigns and private healthcare recommendations, thereby driving overall market growth. Additionally, many countries are expanding adult and senior immunization programs, particularly in regions such as North America, Europe and Asia. These programs increasingly incorporate pneumococcal vaccine as a routine preventive measure. This integrated approach is accelerating vaccine adoption across the aging population segment.  The growing aging population growth contribution during the forecast period in 2024 is 1.50%.

Pneumococcal Vaccine Market Restraints

The key restraints on the pneumococcal vaccine market include:

Cold Chain And Storage Challenges

The cold chain and storage challenges are expected to restrict the growth of the pneumococcal vaccine market, during the forecast period. Pneumococcal vaccines require strict cold chain storage between 2°C and 8°C to maintain efficacy, but poor refrigeration infrastructure in low- and middle-income regions often hinders proper handling. Maintaining this cold chain demands high logistical investment in equipment like refrigerated vehicles and temperature monitors and escalating distribution costs. In remote or underdeveloped areas lacking reliable electricity, consistent storage is challenging, limiting vaccine access and coverage. Geographic and infrastructure barriers further reduce immunization rates in hard-to-reach populations. Additionally, cold chain failures can lead to significant vaccine spoilage, causing financial losses and disrupting immunization efforts. This risk often deters large-scale stockpiling or outreach initiatives.  Growth affected by cold chain and storage challenges during the forecast period in 2024 is -2.00%.

Pneumococcal Vaccine Market Trends

Major trends shaping the pneumococcal vaccine market include:

Innovative Pneumococcal Vaccine Enhances Pediatric Immunization By Targeting Local Disease Burden

Companies operating in the pneumococcal vaccine market are focusing on developing innovative formulations tailored to regional disease patterns and immune response optimization. These advancements aim to improve vaccine effectiveness, address local public health needs and reduce dependence on imported products. For example, in June 2025, CanSino Biologics Inc. (CanSinoBIO) is a China-based biopharmaceutical company launched its pneumococcal conjugate vaccine—iPneucia, a 13 valent formulation tailored to China’s epidemiological needs. Designed with innovative dual carriers Cross-Reacting Material 197 (CRM197 + tetanus toxoid), it enhances immunogenicity while minimizing interference with other vaccines. Clinical data show strong antibody responses against key serotypes prevalent in Chinese children. As a domestically developed alternative to imported vaccines, iPneucia supports national immunization efforts, improves access and strengthens CanSinoBIO’s position in the pediatric vaccine market.

Innovative Conjugate Vaccines Aim To Bridge Global Immunization Gaps

Leading companies in the pneumococcal vaccine market are prioritizing the development of next-generation vaccines with broader serotype coverage and enhanced immune responses. These innovations are designed to address regional variations in disease burden and emerging bacterial strains, with the goal of closing immunization gaps and providing stronger protection for both children and adults. For example, in November 2024, Abbott, a US-based healthcare and medical devices company launched PneumoShield 14, a 14-valent pneumococcal conjugate vaccine (PCV-14) in India, offering the broadest protection for children against pneumococcal bacterial infections. Targeted at children aged six weeks and older, the vaccine covers 14 key serotypes responsible for severe diseases such as pneumonia, meningitis and sepsis. It is administered in three doses at 6, 10 and 14 weeks of age. Compared to existing PCV-10 and PCV-13 vaccines, PneumoShield 14 provides broader coverage and addresses serotypes more prevalent in India. This launch reinforces Abbott’s commitment to strengthening pediatric immunization and improving child health outcomes in high-burden regions.

Opportunities And Recommendations In The Pneumococcal Vaccine Market

Opportunities – The top opportunities in the pneumococcal vaccine market segmented by product type will arise in the pneumococcal conjugate vaccine (PCVs) segment, which will gain $2,185.82 million of global annual sales by 2029. The top opportunities in the pneumococcal vaccine market segmented by route of administration will arise in the intramuscular segment, which will gain $2,132.34 million of global annual sales by 2029. The top opportunities in the pneumococcal vaccine market segmented by distribution channel will arise in the public health agencies segment, which will gain $1,431.99 million of global annual sales by 2029. The top opportunities in the pneumococcal vaccine market segmented by end user will arise in the pediatrics segment, which will gain $1,433.34 million of global annual sales by 2029. The pneumococcal vaccine market size will gain the most in the USA at $983.14 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the pneumococcal vaccine companies to focus on region-specific innovation to drive market penetration, focus on expanding serotype coverage to address regional disease burdens, focus on strengthening product pipelines through targeted R&D investment, focus on adult-specific vaccine development to expand market coverage, focus on advancing conjugate vaccines to improve protection across age groups, focus on expanding pneumococcal conjugate vaccine offerings, focus on scaling intramuscular vaccine delivery, expand in emerging markets, focus on strategic partnerships to strengthen market position and accelerate access, focus on competitive and value-based pricing to maximize market penetration, focus on targeted digital and traditional promotion channels, focus on partnerships and healthcare provider training, focus on strengthening public health agency partnerships and focus on capturing growth in the adult segment.

chesta image

Book your 30 minutes free consultation with our research experts

Contact Us

Pneumococcal Vaccine Market Segmentation

The pneumococcal vaccine market is segmented by product type, by route of administration, by distribution channel and by end user.



By Product Type –


The pneumococcal vaccine market is segmented by product type into:

    • a) Pneumococcal Conjugate Vaccine (PCVs)

    • b) Pneumococcal Polysaccharide Vaccine (PPV)

The pneumococcal conjugate vaccine (PCVs) market was the largest segment of the pneumococcal vaccine market segmented by product type, accounting for 96.68% or $7,664.45 million of the total in 2024. Going forward, the pneumococcal conjugate vaccine (PCVs) segment is expected to be the fastest growing segment in the pneumococcal vaccine market segmented by product type, at a CAGR of 5.15% during 2024-2029.



By Route of Administration –


The pneumococcal vaccine market is segmented by route of administration into:

    • a) Intramuscular

    • b) Subcutaneous

The platforms market was the largest segment of the pneumococcal vaccine market segmented by component, accounting for 61.30% or $4,490.50 million of the total in 2024. Going forward, the platforms segment is expected to be the fastest growing segment in the pneumococcal vaccine market segmented by component, at a CAGR of 15.78% during 2024-2029.



By Distribution Channel –


The pneumococcal vaccine market is segmented by distribution channel into:

    • a) Pharmacies

    • b) Community Clinics

    • c) Public Health Agencies

    • d) Other Distribution Channels

The public health agencies market was the largest segment of the pneumococcal vaccine market segmented by distribution channel, accounting for 47.33% or $3,751.95 million of the total in 2024. Going forward, the public health agencies segment is expected to be the fastest growing segment in the pneumococcal vaccine market segmented by distribution channel, at a CAGR of 6.68% during 2024-2029.



By End User –


The pneumococcal vaccine market is segmented by end user into:

  1. a) Pediatrics

  2. b) Adults

The pediatrics market was the largest segment of the pneumococcal vaccine market segmented by end user, accounting for 77.70% or $6,159.50 million of the total in 2024. Going forward, the adults segment is expected to be the fastest growing segment in the pneumococcal vaccine market segmented by end user, at a CAGR of 6.74% during 2024-2029.



By Geography - The pneumococcal vaccine market is segmented by geography into:

      o Asia Pacific

      • • China

      • • India

      • • Japan

      • • Australia

      • • Indonesia

      • • South Korea

      o North America

      • • USA

      • • Canada

      o South America

      • • Brazil

      o Western Europe

      • • France

      • • Germany

      • • UK

      • • Italy

      • • Spain

      o Eastern Europe

      • • Russia

      o Middle East

      o Africa

North America was the largest region in the pneumococcal vaccine market, accounting for 52.01% or $4,123.11 million of the total in 2024. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the pneumococcal vaccine market will be Asia-Pacific and South America where growth will be at CAGRs of 6.31% and 5.71% respectively. These will be followed by Eastern Europe and Middle East where the markets are expected to grow at CAGRs of 5.35% and 4.57% respectively.

Pneumococcal Vaccine Market Competitive Landscape

Major Competitors are:

  • Pfizer Inc.

  • Merck & Co. Inc.  

  • GlaxoSmithKline plc

  • Serum Institute of India Pvt. Ltd.

  • Walvax Biotechnology Co. Ltd.

    • Other Competitors Include:

  • Biological E. Limited

  • SK Bioscience Co., Ltd.

  • Sanofi

  • GSK

  • Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.

  • Hualan Biological Engineering Inc.

  • Beijing Minhai Biotechnology Limited Company

  • Panacea Biotec

  • Tergene Biotech

  • CanSinoBIO

  • Abbott India Ltd.

  • PnuVax Incorporated

  • Nanolek

  • NPO Petrovax Pharm LLC

  • Sinergium Biotech
    • Author : Abhilash Pyata

      Table Of Contents

      1 Executive Summary

      1.1 Pneumococcal Vaccine – Market Attractiveness And Macro Economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Pneumococcal Vaccine Market Definition And Segmentations

      6.4 Market Segmentation By Product Type

      6.4.1 Pneumococcal Conjugate Vaccine (PCVs)

      6.4.2 Pneumococcal Polysaccharide Vaccine (PPV)

      6.5 Market Segmentation By Route of Administration

      6.5.1 Intramuscular

      6.5.2 Subcutaneous

      6.6 Market Segmentation By Distribution Channel

      6.6.1 Pharmacies

      6.6.2 Community Clinics

      6.6.3 Public Health Agencies

      6.6.4 Other Distribution Channels

      6.7 Market Segmentation By End User

      6.7.1 Pediatrics

      6.7.2 Adults

      7 Major Market Trends

      7.1 Innovative Pneumococcal Vaccine Enhances Pediatric Immunization By Targeting Local Disease Burden

      7.2 Innovative Conjugate Vaccines Aim To Bridge Global Immunization Gaps

      7.3 Strategic Collaborations Accelerate Pneumococcal Vaccine Access

      7.4 New Investment Wave Supports Scalable Pneumococcal Immunization

      7.5 Advancing Adult Immunization Through Serotype-Specific Vaccines

      7.6 Advances In Conjugate Vaccine Technology Improve Adult Immunity

      8 Pneumococcal Vaccine Growth Analysis And Strategic Analysis Framework

      8.1 Pneumococcal Vaccine PESTEL Analysis

      8.1.1 Political

      8.1.2 Economic

      8.1.3 Social

      8.1.4 Technological

      8.1.5 Environmental

      8.1.6 Legal

      8.2 Analysis Of End User (B2B and B2C)

      8.2.1 Pediatrics

      8.2.2 Adults

      8.3 Pneumococcal Vaccine Market Growth Rate Analysis

      8.4 Global Historic Market Growth, 2019 – 2024, Value ($ Million)

      8.4.1 Market Drivers 2019 – 2024

      8.4.2 Market Restraints 2019 – 2024

      8.5 Global Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

      8.6 Forecast Growth Contributors/Factors

      8.6.1 Quantitative Growth Contributors

      8.6.2 Drivers

      8.6.3 Restraints

      8.7 Global Pneumococcal Vaccine Total Addressable Market (TAM)

      9 Pneumococcal Vaccine Market Segmentation

      9.1 Global Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.2 Global Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.3 Global Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.4 Global Pneumococcal Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.5 Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumococcal Conjugate Vaccines (PCVs), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.6 Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumococcal Polysaccharide Vaccine (PPV), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10 Pneumococcal Vaccine Market, Regional and Country Analysis

      10.1 Pneumococcal Vaccine Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.2 Pneumococcal Vaccine Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11 Asia-Pacific Market

      11.1 Summary

      11.2 Market Overview

      11.2.1 Region Information

      11.2.2 Market Information

      11.2.3 Background Information

      11.2.4 Government Initiatives

      11.2.5 Regulations

      11.2.6 Regulatory Bodies

      11.2.7 Major Associations

      11.2.8 Taxes Levied

      11.2.9 Corporate Tax Structure

      11.2.10 Investments

      11.2.11 Major Companies

      11.3 Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.4 Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.5 Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.6 Asia-Pacific Pneumococcal Vaccine Market: Country Analysis

      11.7 China Market

      11.8 Summary

      11.9 Market Overview

      11.9.1 Country Information

      11.9.2 Market Information

      11.9.3 Background Information

      11.9.4 Government Initiatives

      11.9.5 Regulations

      11.9.6 Regulatory Bodies

      11.9.7 Major Associations

      11.9.8 Taxes Levied

      11.9.9 Corporate Tax Structure

      11.9.10 Investments

      11.9.11 Major Companies

      11.10 China Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.11 China Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.12 China Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.13 India Market

      11.14 India Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.15 India Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.16 India Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.17 Japan Market

      11.18 Summary

      11.19 Market Overview

      11.19.1 Country Information

      11.19.2 Market Information

      11.19.3 Background Information

      11.19.4 Government Initiatives

      11.19.5 Regulatory Bodies

      11.19.6 Major Associations

      11.19.7 Taxes Levied

      11.19.8 Corporate Tax Structure

      11.19.9 Investments

      11.19.10 Major Companies

      11.20 Japan Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.21 Japan Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.22 Japan Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.23 Australia Market

      11.24 Australia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.25 Australia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.26 Australia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.27 Indonesia Market

      11.28 Indonesia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.29 Indonesia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.30 Indonesia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.31 South Korea Market

      11.32 Summary

      11.33 Market Overview

      11.33.1 Country Information

      11.33.2 Market Information

      11.33.3 Background Information

      11.33.4 Government Initiatives

      11.33.5 Regulations

      11.33.6 Regulatory Bodies

      11.33.7 Major Associations

      11.33.8 Taxes Levied

      11.33.9 Corporate Tax Structure

      11.33.10 Investments

      11.33.11 Major Companies

      11.34 South Korea Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.35 South Korea Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.36 South Korea Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12 Western Europe Market

      12.1 Summary

      12.2 Market Overview

      12.2.1 Region Information

      12.2.2 Market Information

      12.2.3 Background Information

      12.2.4 Government Initiatives

      12.2.5 Regulations

      12.2.6 Regulatory Bodies

      12.2.7 Major Associations

      12.2.8 Taxes Levied

      12.2.9 Corporate tax structure

      12.2.10 Investments

      12.2.11 Major Companies

      12.3 Western Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.4 Western Europe Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.5 Western Europe Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.6 Western Europe Pneumococcal Vaccine Market: Country Analysis

      12.7 UK Market

      12.8 UK Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.9 UK Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.10 UK Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.11 Germany Market

      12.12 Germany Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.13 Germany Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.14 Germany Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.15 France Market

      12.16 France Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.17 France Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.18 France Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.19 Italy Market

      12.20 Italy Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.21 Italy Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.22 Italy Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.23 Spain Market

      12.24 Spain Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.25 Spain Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.26 Spain Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13 Eastern Europe Market

      13.1 Summary

      13.2 Market Overview

      13.2.1 Region Information

      13.2.2 Market Information

      13.2.3 Background Information

      13.2.4 Government Initiatives

      13.2.5 Regulations

      13.2.6 Regulatory Bodies

      13.2.7 Major Associations

      13.2.8 Taxes Levied

      13.2.9 Corporate Tax Structure

      13.2.10 Investments

      13.2.11 Major Companies

      13.3 Eastern Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.4 Eastern Europe Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.5 Eastern Europe Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.6 Eastern Europe Pneumococcal Vaccine Market: Country Analysis

      13.7 Russia Market

      13.8 Russia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.9 Russia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.10 Russia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14 North America Market

      14.1 Summary

      14.2 Market Overview

      14.2.1 Region Information

      14.2.2 Market Information

      14.2.3 Background Information

      14.2.4 Government Initiatives

      14.2.5 Regulations

      14.2.6 Regulatory Bodies

      14.2.7 Major Associations

      14.2.8 Taxes Levied

      14.2.9 Corporate Tax Structure

      14.2.10 Investments

      14.2.11 Major Companies

      14.3 North America Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.4 North America Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.5 North America Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.6 North America Pneumococcal Vaccine Market: Country Analysis

      14.7 USA Market

      14.8 Summary

      14.9 Market Overview

      14.9.1 Country Information

      14.9.2 Market Information

      14.9.3 Background Information

      14.9.4 Government Initiatives

      14.9.5 Regulations

      14.9.6 Regulatory Bodies

      14.9.7 Major Associations

      14.9.8 Taxes Levied

      14.9.9 Corporate Tax Structure

      14.9.10 Investments

      14.9.11 Major Companies

      14.10 USA Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.11 USA Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.12 USA Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.13 Canada Market

      14.14 Summary

      14.15 Market Overview

      14.15.1 Country Information

      14.15.2 Market Information

      14.15.3 Background Information

      14.15.4 Government Initiatives

      14.15.5 Regulations

      14.15.6 Regulatory Bodies

      14.15.7 Major Associations

      14.15.8 Taxes Levied

      14.15.9 Corporate Tax Structure

      14.15.10 Investments

      14.15.11 Major Companies

      14.16 Canada Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.17 Canada Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.18 Canada Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15 South America Market

      15.1 Summary

      15.2 Market Overview

      15.2.1 Region Information

      15.2.2 Market Information

      15.2.3 Background Information

      15.2.4 Government Initiatives

      15.2.5 Regulations

      15.2.6 Regulatory Bodies

      15.2.7 Major Associations

      15.2.8 Taxes Levied

      15.2.9 Corporate Tax Structure

      15.2.10 Investments

      15.2.11 Major Companies

      15.3 South America Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.4 South America Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.5 South America Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.6 South America Pneumococcal Vaccine Market: Country Analysis

      15.7 Brazil Market

      15.8 Brazil Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.9 Brazil Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.10 Brazil Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16 Middle East Market

      16.1 Summary

      16.2 Market Overview

      16.2.1 Region Information

      16.2.2 Market Information

      16.2.3 Background Information

      16.2.4 Government Initiatives

      16.2.5 Regulations

      16.2.6 Regulatory Bodies

      16.2.7 Major Associations

      16.2.8 Taxes Levied

      16.2.9 Corporate Tax Structure

      16.2.10 Investments

      16.2.11 Major Companies

      16.3 Middle East Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.4 Middle East Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.5 Middle East Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17 Africa Market

      17.1 Summary

      17.2 Market Overview

      17.2.1 Region Information

      17.2.2 Market Information

      17.2.3 Background Information

      17.2.4 Government Initiatives

      17.2.5 Regulations

      17.2.6 Regulatory Bodies

      17.2.7 Major Associations

      17.2.8 Taxes Levied

      17.2.9 Corporate Tax Structure

      17.2.10 Investments

      17.2.11 Major Companies

      17.3 Africa Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.4 Africa Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.5 Africa Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18 Competitive Landscape And Company Profiles

      18.1 Company Profiles

      18.2 Pfizer Inc

      18.2.1 Company Overview

      18.2.2 Products And Services

      18.2.3 Business Strategy

      18.2.4 Financial Overview

      18.3 Merck & Co., Inc.

      18.3.1 Company Overview

      18.3.2 Products And Services

      18.3.3 Business Strategy

      18.3.4 Financial Overview

      18.4 GlaxoSmithKline plc

      18.4.1 Company Overview

      18.4.2 Products And Services

      18.4.3 Financial Overview

      18.5 Serum Institute of India Pvt. Ltd

      18.5.1 Company Overview

      18.5.2 Products And Services

      18.5.3 Business Strategy

      18.5.4 Financial Overview

      18.6 Walvax Biotechnology Co. Ltd

      18.6.1 Company Overview

      18.6.2 Products And Services

      18.6.3 Financial Overview

      19 Other Major And Innovative Companies

      19.1 Biological E. Limited

      19.1.1 Company Overview

      19.1.2 Products And Services

      19.2 Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.3 Shenzhen Kangtai Biological Products Co. Ltd. (Beijing Minhai Biotechnology Corporation Limited)

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.4 NPO Petrovax Pharm LLC

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.5 SK Bioscience Co. Ltd.

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.6 Vaxcyte, Inc.

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.7 Sinovac Biotech Ltd.

      19.7.1 Company Overview

      19.7.2 Products And Services

      19.8 Astellas Pharma Inc.

      19.8.1 Company Overview

      19.8.2 Products And Services

      19.9 LG Chem Ltd.

      19.9.1 Company Overview

      19.9.2 Products And Services

      19.10 AIM Vaccine Co. Ltd.

      19.10.1 Company Overview

      19.10.2 Products And Services

      19.11 Panacea Biotec Limited

      19.11.1 Company Overview

      19.11.2 Products And Services

      19.12 China National Biotec Group (CNBG)

      19.12.1 Company Overview

      19.12.2 Products And Services

      19.13 Inventprise LLC

      19.13.1 Company Overview

      19.13.2 Products And Services

      19.14 Pnuvax Incorporated

      19.14.1 Company Overview

      19.14.2 Products And Services

      19.15 Tergene Biotech Private Limited

      19.15.1 Company Overview

      19.15.2 Products And Services

      20 Competitive Benchmarking

      21 Competitive Dashboard

      22 Key Mergers And Acquisitions

      22.1 SK bioscience Co. Ltd Acquired Fina Biosolutions

      22.2 GSK Plc Acquired Affinivax

      23 Recent Developments In The Pneumococcal Vaccine Market

      23.1 New Pneumococcal Vaccine Launch Targets Nationwide Adult Protection

      23.2 Next-Generation Pneumococcal Vaccine Approval Targets Drug-Resistant Strains

      24 Opportunities And Strategies

      24.1 Pneumococcal Vaccine Market In 2029 – Countries Offering Most New Opportunities

      24.2 Pneumococcal Vaccine Market In 2029 – Segments Offering Most New Opportunities

      24.3 Pneumococcal Vaccine Market In 2029 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 Pneumococcal Vaccine Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Pneumococcal Vaccine Market, Historic, 2019 – 2024, $ Million
    • Table 2: Pneumococcal Vaccine Market, Forecast, 2024 – 2029, 2034F, $ Million
    • Table 3: Global Pneumococcal Vaccine Market TAM, 2024 And 2034, $ Million
    • Table 4: Global Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 5: Global Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 6: Global Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 7: Global Pneumococcal Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 8: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumococcal Conjugate Vaccines (PCVs), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 9: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumococcal Polysaccharide Vaccine (PPV), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 10: Pneumococcal Vaccine Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 11: Pneumococcal Vaccine Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 12: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $
    • Table 13:  Asia-Pacific Population, By Country, 2019-2029, Millions
    • Table 14: Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 15: Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 16: Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 17: China GDP Per Capita, 2019-2024, $
    • Table 18:  China Population, 2019-2029, Millions
    • Table 19: China Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 20: China Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 21: China Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 22: India Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 23: India Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 24: India Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 25: Japan GDP Per Capita, 2019-2024, $
    • Table 26:  Japan Population, By Country, 2019-2029, Millions
    • Table 27: Japan Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 28: Japan Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 29: Japan Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 30: Australia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 31: Australia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 32: Australia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 33: Indonesia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 34: Indonesia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 35: Indonesia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 36: South Korea GDP Per Capita, 2019-2024, $
    • Table 37:  South Korea Population, 2019-2029, Millions
    • Table 38: South Korea Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 39: South Korea Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 40: South Korea Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 41: Western Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 42:  Western Europe Population, By Country, 2019-2029, Millions
    • Table 43: Western Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 44: Western Europe Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 45: Western Europe Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 46: UK Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 47: UK Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 48: UK Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 49: Germany Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 50: Germany Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 51: Germany Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 52: France Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 53: France Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 54: France Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 55: Italy Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 56: Italy Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 57: Italy Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 58: Spain Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 59: Spain Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 60: Spain Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 61: Eastern Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 62:  Eastern Europe Population, By Country, 2019-2029, Millions
    • Table 63: Eastern Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 64: Eastern Europe Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 65: Eastern Europe Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 66: Russia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 67: Russia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 68: Russia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 69: North America GDP Per Capita, By Country, 2019-2024, $
    • Table 70:  North America Population, By Country, 2019-2029, Millions
    • Table 71: North America Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 72: North America Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 73: North America Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 74: USA GDP Per Capita, 2019-2024, $
    • Table 75:  USA Population, 2019-2029, Millions
    • Table 76: USA Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 77: USA Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 78: USA Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 79: Canada GDP Per Capita, 2019-2024, $
    • Table 80:  Canada Population, By Country, 2019-2029, Millions
    • Table 81: Canada Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 82: Canada Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 83: Canada Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 84: South America GDP Per Capita, By Country, 2019-2024, $
    • Table 85:  South America Population, By Country, 2019-2029, Millions
    • Table 86: South America Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 87: South America Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 88: South America Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 89: Brazil Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 90: Brazil Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 91: Brazil Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 92: Middle East GDP Per Capita, By Country, 2019-2024, $
    • Table 93:  Middle East Population, By Country, 2019-2029, Millions
    • Table 94: Middle East Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 95: Middle East Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 96: Middle East Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 97: Africa GDP Per Capita, By Country, 2019-2024, $
    • Table 98:  Africa Population, By Country, 2019-2029, Millions
    • Table 99: Africa Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 100: Africa Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 101: Africa Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 102: Global Pneumococcal Vaccine Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Table 103: Pfizer Inc – Financial Overview, 2019 – 2023, $Billion
    • Table 104: Merck & Co., Inc – Financial Overview, 2019 – 2023, $Billion
    • Table 105: GlaxoSmithKline plc – Financial Overview, 2019 – 2023, $ Billion
    • Table 106: Serum Institute of India Pvt. Ltd – Financial Overview, 2023, $Billion
    • Table 107: Walvax Biotechnology Co. Ltd – Financial Overview, 2023, $Million
    • Table 108: Pneumococcal Vaccine Market, Competitive Benchmarking (In USD Millions)
    • Table 109: Pneumococcal Vaccine Market, Competitive Dashboard
    • Table 110: Pneumococcal Vaccine Market Size Gain ($ Million), 2024 – 2029, By Country
    • Table 111: Pneumococcal Vaccine Market Size Gain ($ Million), Segmentation By Product Type, 2024 – 2029
    • Table 112: Pneumococcal Vaccine Market Size Gain ($ Million), Segmentation By Route Of Administration, 2024 – 2029
    • Table 113: Pneumococcal Vaccine Market Size Gain ($ Million), Segmentation By Distribution Channel, 2024 – 2029
    • Table 114: Pneumococcal Vaccine Market Size Gain ($ Million), Segmentation By End User, 2024 – 2029
    • Table 115: Pneumococcal Vaccine Market Data Sources

    List Of Figures

      Figure 1: Global Pneumococcal Vaccine Market Segmentation By Product Type
    • Figure 2: Global Pneumococcal Vaccine Market Segmentation By Route of Administration
    • Figure 3: Global Pneumococcal Vaccine Market Segmentation By Distribution Channel
    • Figure 4: Global Pneumococcal Vaccine Market Segmentation By End User
    • Figure 5: Global Pneumococcal Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
    • Figure 6: Pneumococcal Vaccine Market, Historic, 2019 – 2024, $ Million
    • Figure 7: Pneumococcal Vaccine Market, Forecast, 2024 – 2029, 2034F, $ Million
    • Figure 8: Global Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 9: Global Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 10: Global Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 11: Global Pneumococcal Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 12: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumococcal Conjugate Vaccines (PCVs), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 13: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumococcal Polysaccharide Vaccine (PPV), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 14: Pneumococcal Vaccine Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 15: Pneumococcal Vaccine Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 16: Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 17: Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 18: Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 19: China Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 20: China Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 21: China Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 22: India Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 23: India Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 24: India Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 25: Japan Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 26: Japan Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 27: Japan Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 28: Australia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 29: Australia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 30: Australia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 31: Indonesia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 32: Indonesia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 33: Indonesia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 34: South Korea Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 35: South Korea Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 36: South Korea Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 37: Western Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 38: Western Europe Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 39: Western Europe Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 40: UK Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 41: UK Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 42: UK Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 43: Germany Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 44: Germany Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 45: Germany Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 46: France Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 47: France Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 48: France Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 49: Italy Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 50: Italy Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 51: Italy Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 52: Spain Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 53: Spain Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 54: Spain Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 55: Eastern Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 56: Eastern Europe Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 57: Eastern Europe Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 58: Russia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 59: Russia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 60: Russia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 61: North America Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 62: North America Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 63: North America Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 64: USA Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 65: USA Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 66: USA Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 67: Canada Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 68: Canada Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 69: Canada Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 70: South America Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 71: South America Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 72: South America Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 73: Brazil Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 74: Brazil Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 75: Brazil Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 76: Middle East Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 77: Middle East Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 78: Middle East Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 79: Africa Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 80: Africa Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 81: Africa Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 82: Global Pneumococcal Vaccine, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Figure 83: Pfizer Inc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 84: Merck & Co., Inc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 85: GlaxoSmithKline plc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 86: Geographic Regions Covered

    Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

    Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

    Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

    Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

    2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

    Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

    Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

    Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

    Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

    Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

    CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

    Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

    Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

    Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

    Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

    Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

    Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

    Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

    Microbiome Market Report 2026 - Global Outlook – By Microbe Category (Bacteria, Archaea, Viruses, Other Microbiomes), By Product (Therapeutics, Diagnostics), By Technology (Genomics, Proteomics, Metabolomics), By End-Use...

    Oral Biologics & Biosimilar Drugs Market Report 2026 - Global Outlook – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, ...

    Corticosteroids Market Report 2026 - Global Outlook – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applicati...

    Back to top